JPS6163618A - 下剤 - Google Patents
下剤Info
- Publication number
- JPS6163618A JPS6163618A JP59184931A JP18493184A JPS6163618A JP S6163618 A JPS6163618 A JP S6163618A JP 59184931 A JP59184931 A JP 59184931A JP 18493184 A JP18493184 A JP 18493184A JP S6163618 A JPS6163618 A JP S6163618A
- Authority
- JP
- Japan
- Prior art keywords
- lactose
- lactic acid
- cathartic
- laxative
- mesh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 88
- 239000008101 lactose Substances 0.000 claims abstract description 86
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 62
- 241000894006 Bacteria Species 0.000 claims abstract description 39
- 239000004310 lactic acid Substances 0.000 claims abstract description 31
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 31
- 239000002245 particle Substances 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 235000016709 nutrition Nutrition 0.000 claims abstract description 10
- 239000008141 laxative Substances 0.000 claims description 45
- 230000002475 laxative effect Effects 0.000 claims description 34
- 241000233866 Fungi Species 0.000 claims description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 10
- 239000002075 main ingredient Substances 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 26
- 210000000936 intestine Anatomy 0.000 abstract description 20
- 210000002784 stomach Anatomy 0.000 abstract description 17
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract description 16
- 206010047700 Vomiting Diseases 0.000 abstract description 6
- 238000000855 fermentation Methods 0.000 abstract description 6
- 230000004151 fermentation Effects 0.000 abstract description 6
- 238000000354 decomposition reaction Methods 0.000 abstract description 5
- 230000008673 vomiting Effects 0.000 abstract description 5
- 206010028813 Nausea Diseases 0.000 abstract description 4
- 230000008693 nausea Effects 0.000 abstract description 3
- -1 and a mold (e.g. Substances 0.000 abstract description 2
- 235000011089 carbon dioxide Nutrition 0.000 abstract 2
- 230000035764 nutrition Effects 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940068140 lactobacillus bifidus Drugs 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 239000004615 ingredient Substances 0.000 description 14
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 13
- 235000010413 sodium alginate Nutrition 0.000 description 13
- 229940005550 sodium alginate Drugs 0.000 description 13
- 239000000661 sodium alginate Substances 0.000 description 13
- 229940125722 laxative agent Drugs 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 241000209094 Oryza Species 0.000 description 8
- 235000007164 Oryza sativa Nutrition 0.000 description 8
- 235000021329 brown rice Nutrition 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 235000009566 rice Nutrition 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- 239000001569 carbon dioxide Substances 0.000 description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 206010056325 Faecaloma Diseases 0.000 description 4
- 208000008415 Fecal Impaction Diseases 0.000 description 4
- 230000013872 defecation Effects 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 150000002597 lactoses Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010015995 Eyelid ptosis Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000741 diarrhetic effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 201000003004 ptosis Diseases 0.000 description 1
- 230000001543 purgative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59184931A JPS6163618A (ja) | 1984-09-03 | 1984-09-03 | 下剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59184931A JPS6163618A (ja) | 1984-09-03 | 1984-09-03 | 下剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6163618A true JPS6163618A (ja) | 1986-04-01 |
| JPH0368010B2 JPH0368010B2 (OSRAM) | 1991-10-25 |
Family
ID=16161848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59184931A Granted JPS6163618A (ja) | 1984-09-03 | 1984-09-03 | 下剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6163618A (OSRAM) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6363620A (ja) * | 1986-09-03 | 1988-03-22 | Toa Yakuhin Kogyo Kk | ３種菌共生混合物 |
| US20110086093A1 (en) * | 1998-07-07 | 2011-04-14 | Ritter Pharmaceuticals, Inc. | Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
| US9226933B2 (en) | 2004-07-22 | 2016-01-05 | Ritter Pharmaceuticals, Inc. | Methods and compositions for treating lactose intolerance |
| US9579340B2 (en) | 2009-02-24 | 2017-02-28 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| US9592248B2 (en) | 2009-02-24 | 2017-03-14 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS555490A (en) * | 1978-05-30 | 1980-01-16 | Gen Electric | Cooling system for gas turbine |
| JPS588018A (ja) * | 1981-07-07 | 1983-01-18 | Akira Yamauchi | 下剤 |
-
1984
- 1984-09-03 JP JP59184931A patent/JPS6163618A/ja active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS555490A (en) * | 1978-05-30 | 1980-01-16 | Gen Electric | Cooling system for gas turbine |
| JPS588018A (ja) * | 1981-07-07 | 1983-01-18 | Akira Yamauchi | 下剤 |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6363620A (ja) * | 1986-09-03 | 1988-03-22 | Toa Yakuhin Kogyo Kk | ３種菌共生混合物 |
| US20110086093A1 (en) * | 1998-07-07 | 2011-04-14 | Ritter Pharmaceuticals, Inc. | Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
| US9226933B2 (en) | 2004-07-22 | 2016-01-05 | Ritter Pharmaceuticals, Inc. | Methods and compositions for treating lactose intolerance |
| US9579340B2 (en) | 2009-02-24 | 2017-02-28 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| US9592248B2 (en) | 2009-02-24 | 2017-03-14 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| US9775860B2 (en) | 2009-02-24 | 2017-10-03 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| US9808481B2 (en) | 2009-02-24 | 2017-11-07 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0368010B2 (OSRAM) | 1991-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE502007010071C5 (de) | Verwendung einer zusammensetzung aus mineralstoffen und gegebenenfalls acetogenen und/oder butyrogenen bakterien zur vermeidung oder reduzierung von gasbildung im dickdarm eines säugetiers und dadurch bedingter abdominaler beschwerden | |
| JP2002508772A (ja) | 健康補助剤 | |
| EP1133306A1 (en) | Herbal and pharmaceutical drugs enhanced with probiotics | |
| US11523989B2 (en) | Method to improve the health of the microbiome in a human gastrointestinal system and multi-chamber probiotic delivery products therefor | |
| WO1994001099A1 (fr) | Composition pharmaceutique presentant des actions anti-alcool stimulant le metabolisme de l'energie, stimulant les fonctions de production et de secretion d'acide de la membrane muqueuse de l'estomac, et presentant egalement des actions radioprotectrice et anti-cholera | |
| JPH07242557A (ja) | 乳酸菌含有瀉下薬組成物 | |
| CN104107188B (zh) | 苹果多糖调节肠道菌群失调及润肠通便的用途及其制备方法 | |
| CN104415061B (zh) | 可食用组合物及其制备方法和用途 | |
| WO2001078649A2 (en) | Pharmaceutical curative compound | |
| GB2122488A (en) | Compositions containing papain and citric acid | |
| CN114343180A (zh) | 一种具有通腑排毒作用的系列组合物及其应用 | |
| JPS6163618A (ja) | 下剤 | |
| JP2000245391A (ja) | 健康食品 | |
| CN108245531A (zh) | 一种改善胃肠道功能、防治便秘的组合物 | |
| CN100381136C (zh) | 一种治疗便秘的药物组合物及其制剂和制备方法 | |
| KR100363999B1 (ko) | 갱년기 이후 우울증 및 신경쇠약 개선 음료 조성물 및이의 제조방법 | |
| CN100401920C (zh) | 具有润肠通便功能的膳食纤维组合物及其生产方法 | |
| JPH09505824A (ja) | 便秘の治療におけるジメチコーンの使用 | |
| RU2070050C1 (ru) | Средство для стимуляции моторно-эвакуаторной функции кишечника у детей | |
| RU2225219C1 (ru) | Способ производства адаптогена со свойствами сорбента | |
| DE102015114857A1 (de) | Getränk, enthaltend eine pharmazeutische Zusammensetzung | |
| CN104800789A (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
| RU2246958C1 (ru) | Биологически активный препарат для коррекции нарушений микрофлоры желудочно-кишечного тракта и повышения общей резистентности организма | |
| JPS6355493B2 (OSRAM) | ||
| CN108669530A (zh) | 一种利于肠胃健康的猴头菇组合物、片剂及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |